Its world-class facilities are built for adaptability, scalability, and long-term growth, providing an optimal environment for life sciences enterprises

Rx Propellant, India’s premier life sciences infrastructure platform backed by Actis, unveils 1GV, a cutting-edge 136,000 sq ft research and innovation campus built over 1.8 acre in Genome Valley, Hyderabad.

Over the years, the campus has been instrumental in scientific breakthroughs, witnessing and contributing to the evolution of India’s pharmaceutical, biotech, and contract research industries. This campus is a continuation of the legacy of the evolution of the Indian pharmaceutical and biotech industry, as 1GV is built on the historical grounds of the first construction in Genome Valley.
 
1GV is a beacon of modern life sciences infrastructure, designed to integrate sustainability at its core. With LEED Platinum & IFC EDGE Advanced Pre-Certification, the campus reflects a commitment to environmentally responsible development. Its world-class facilities are built for adaptability, scalability, and long-term growth, providing an optimal environment for life sciences enterprises. Beyond infrastructure, 1GV offers a suite of collaborative spaces designed to enhance connectivity, comfort, and well-being.

“The launch of 1GV marks a significant expansion of Rx Propellant's owned portfolio, now totalling three campuses, and reinforces our leadership in India's life sciences infrastructure. The strategic addition in Genome Valley, a key hub, strengthens our presence in Hyderabad and contributes to our broader pan-India vision of providing cutting-edge, sustainable infrastructure to support the sector's growth,” said Milind Ravi, CEO, Rx Propellant.